AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015
Feb 10, 2015
30583_dirs_2015-02-10_e7538ca1-9279-4bbc-ba1e-fbbbc364267a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-03-18
Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-18 | Common Stock | A | 7 | $61.4829 | Acquired | 68683 | Direct |
| 2013-03-18 | Common Stock | A | 7 | $61.3814 | Acquired | 68690 | Direct |
| 2013-03-20 | Common Stock | A | 5 | $61.9880 | Acquired | 68695 | Direct |
| 2013-03-20 | Common Stock | A | 4 | $61.4325 | Acquired | 68699 | Direct |
| 2013-06-19 | Common Stock | A | 9 | $58.5678 | Acquired | 68708 | Direct |
| 2013-06-19 | Common Stock | A | 9 | $58.8478 | Acquired | 68717 | Direct |
| 2013-09-10 | Common Stock | A | 8 | $70.0583 | Acquired | 68725 | Direct |
| 2013-09-10 | Common Stock | A | 7 | $70.3029 | Acquired | 68732 | Direct |
| 2013-10-04 | Common Stock | A | 5 | $74.0740 | Acquired | 68737 | Direct |
| 2013-10-07 | Common Stock | A | 6 | $74.8383 | Acquired | 68743 | Direct |
| 2013-10-30 | Common Stock | A | 4 | $66.4750 | Acquired | 68747 | Direct |
| 2013-10-30 | Common Stock | A | 5 | $65.7500 | Acquired | 68752 | Direct |
| 2013-11-20 | Common Stock | A | 8 | $65.8863 | Acquired | 68760 | Direct |
| 2014-03-05 | Common Stock | S | 12 | $82.9258 | Disposed | 68748 | Direct |
| 2014-05-02 | Common Stock | S | 3 | $58.0233 | Disposed | 68745 | Direct |
| 2014-05-02 | Common Stock | S | 8 | $58.7800 | Disposed | 68737 | Direct |
| 2014-08-06 | Common Stock | A | 7 | $62.1671 | Acquired | 68744 | Direct |
| 2014-08-06 | Common Stock | A | 7 | $62.1771 | Acquired | 68751 | Direct |
| 2014-09-03 | Common Stock | S | 9 | $69.8289 | Disposed | 68742 | Direct |
| 2014-09-03 | Common Stock | S | 9 | $69.7011 | Disposed | 68733 | Direct |
Footnotes
F1: Inadvertent transaction not directed by the reporting person through a broker-administered investment pool.
F2: Some of the transactions executed as reported herein resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"). The Reporting Person has made arrangements with the Issuer to disgorge short swing profits realized to the Issuer, and upon settlement, the Reporting Person will have discharged in full any obligation under Section 16(b) with respect to the reported transactions.